Is Senseonics a Winning Diabetes Stock to Own in 2022?

Diabetes-focused medical company Senseonics (SENS) reported top- and bottom-line growth in its last reported quarter. But is it wise to bet on the stock now despite the intense competition it…

Leave a comment

Your email address will not be published. Required fields are marked *